|
8921 |
Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial
Enthalten in Trials Bd. 23, 28.12.2022, Nr. 1, date:12.2022: 1-12
|
|
|
|
8922 |
Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial
Enthalten in Trials Bd. 19, 13.7.2018, Nr. 1, date:12.2018: 1-7
|
|
|
|
8923 |
Safety and organ health with 8 weeks use of commercially available bio-active peptide supplement: A prospective, double-blind, placebo controlled randomized trial
Enthalten in Proceedings of the ... International Society of Sports Nutrition (ISSN) Conference and Expo Bd. 12, 21.9.2015, Nr. 1, date:12.2015: 1-2
|
|
|
|
8924 |
Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover study
Enthalten in BMC musculoskeletal disorders Bd. 17, 16.7.2016, Nr. 1, date:12.2016: 1-10
|
|
|
|
8925 |
Safety and Pharmacokinetics of HRS-2261, a P2X3 Receptor Antagonist, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
Enthalten in Clinical pharmacokinetics Bd. 63, 10.1.2024, Nr. 3, date:3.2024: 293-302
|
|
|
|
8926 |
Safety and Pharmacokinetics of PSD502 in Healthy Chinese Male and Female Volunteers: Two Randomized, Double-Blind, Placebo-Controlled, Phase I Trials
Enthalten in Clinical drug investigation Bd. 43, 28.6.2023, Nr. 7, date:7.2023: 503-515
|
|
|
|
8927 |
Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate-to-severe ARDS—a randomized, placebo-controlled, double-blind trial
Enthalten in Trials Bd. 22, 20.9.2021, Nr. 1, date:12.2021: 1-21
|
|
|
|
8928 |
Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate to severe ARDS in a randomized, placebo-controlled, double-blind trial: preliminary evaluation of safety and feasibility in light of the COVID-19 pandemic
Enthalten in Trials Bd. 23, 4.4.2022, Nr. 1, date:12.2022: 1-6
|
|
|
|
8929 |
Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study
Enthalten in Arthritis Research & Therapy Bd. 18, 7.6.2016, Nr. 1, date:12.2016: 1-14
|
|
|
|
8930 |
Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial
Enthalten in Osteoporosis international Bd. 22, 10.6.2010, Nr. 2, date:2.2011: 567-576
|
|
Administration
